TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’
23 mai 2024 07h00 HE | Tilray Brands, Inc.
TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- May 23, 2024 – Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company today announces the latest...
IMG_5056
Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects. 
17 avr. 2024 10h15 HE | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most...
nsNQO4ef_400x400.png
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
16 avr. 2024 08h00 HE | Right On Brands, Inc.
OTC:RTON will begin marketing the super premium products of HONEY® Brands throughout its growing network of retailers.
nsNQO4ef_400x400.png
Right On Brands, Inc. Continues Rollout, Announces 13th Store Opening
10 avr. 2024 08h15 HE | Right On Brands, Inc.
DALLAS, April 10, 2024 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON) ("RTON" or the "Company"), a fully reporting SEC company and a leading developer of a diverse range of hemp-based...
nsNQO4ef_400x400.png
Right On Brands, Inc. Continues Impressive Rollout, Announces 12th Store Opening
14 mars 2024 08h00 HE | Right On Brands, Inc.
Right on Brands, Inc. (OTC PINK: RTON) is opening its 12th licensed store in the fastest growing county in the country.
Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals prepares to begin IND-enabling studies for DB-007-4, a potential best-in-class treatment for inflammatory skin diseases
27 févr. 2024 10h00 HE | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver-based biopharmaceutical company developing novel topical therapies for inflammatory skin...
Transparency Market Research
Topical Antibiotics Market Size Projected to Reach USD 10.0 billion by 2031, With 5.1% CAGR: Transparency Market Research, Inc.
21 févr. 2024 00h40 HE | Transparency Market Research
Wilmington, Delaware, United States, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global topical antibiotics market is estimated to flourish at a CAGR of 5.1% from 2023...
Research Nester Logo.jpg
Hemostasis Products Market revenue to hit USD 1.73 Billion by 2033, says Research Nester
06 févr. 2024 07h30 HE | Research Nester
New York, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The global hemostasis products market size is estimated to attain at ~5.1% CAGR from 2023 to 2033. The market is expected to garner a revenue of USD 1.73...
Research Nester Logo.jpg
Compounding Pharmacies Market revenue to exceed USD 27 Billion by 2035, says Research Nester
22 janv. 2024 05h30 HE | Research Nester
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global compounding pharmacies market size is slated to expand at ~9% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 27...
Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals Announces Collaboration with Massachusetts General Hospital in Skin Cancer Study
28 nov. 2023 10h00 HE | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver based biopharmaceutical company with a focus on skin disease, is excited to announce that...